{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:07:37Z","timestamp":1791223657352,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T00:00:00Z","timestamp":1458691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.vaccine.2016.03.072","type":"journal-article","created":{"date-parts":[[2016,3,30]],"date-time":"2016-03-30T01:12:51Z","timestamp":1459300371000},"page":"2907-2910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Nontyphoidal salmonella disease: Current status of vaccine research and development"],"prefix":"10.1016","volume":"34","author":[{"given":"Sharon M.","family":"Tennant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calman A.","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura B.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Imran","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.03.072_bib0005","series-title":"Medical microbiology","author":"Murray","year":"2005"},{"issue":"9835","key":"10.1016\/j.vaccine.2016.03.072_bib0010","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/S0140-6736(11)61752-2","article-title":"Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa","volume":"379","author":"Feasey","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2016.03.072_bib0015","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1086\/650733","article-title":"The global burden of nontyphoidal Salmonella gastroenteritis","volume":"50","author":"Majowicz","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2016.03.072_bib0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1473-3099(10)70072-4","article-title":"Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis","volume":"10","author":"Reddy","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2016.03.072_bib0025","doi-asserted-by":"crossref","DOI":"10.3201\/eid2106.140999","article-title":"Global burden of invasive nontyphoidal salmonella disease, 2010","volume":"21","author":"Ao","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2016.03.072_bib0030","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/00002030-200208160-00009","article-title":"Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence","volume":"16","author":"Gordon","year":"2002","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.vaccine.2016.03.072_bib0035","doi-asserted-by":"crossref","first-page":"e621","DOI":"10.1371\/journal.pntd.0000621","article-title":"Identification by PCR of non-typhoidal Salmonella enterica serovars associated with invasive infections among febrile patients in Mali","volume":"4","author":"Tennant","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2016.03.072_bib0040","doi-asserted-by":"crossref","DOI":"10.4161\/hv.29054","article-title":"Vaccines against invasive Salmonella disease: current status and future directions","volume":"10","author":"Maclennan","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"10.1016\/j.vaccine.2016.03.072_bib0045","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/QCO.0b013e32834a9980","article-title":"Invasive nontyphoidal Salmonella disease: epidemiology, pathogenesis and diagnosis","volume":"24","author":"Gordon","year":"2011","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2016.03.072_bib0050","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1172\/JCI33998","article-title":"The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children","volume":"118","author":"MacLennan","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2016.03.072_bib0055","unstructured":"Part D. Guidelines on the quality, safety and efficacy of typhoid conjugate vaccines."},{"issue":"4","key":"10.1016\/j.vaccine.2016.03.072_bib0060","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.4049\/jimmunol.1000284","article-title":"Absent bactericidal activity of mouse serum against invasive African nontyphoidal Salmonella results from impaired complement function but not a lack of antibody","volume":"186","author":"Siggins","year":"2011","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2016.03.072_bib0065","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1128\/CVI.00115-14","article-title":"Serum bactericidal assays to evaluate typhoidal and nontyphoidal Salmonella vaccines","volume":"21","author":"Boyd","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2016.03.072_bib0070","doi-asserted-by":"crossref","first-page":"e64680","DOI":"10.1371\/journal.pone.0064680","article-title":"Sustained protection in mice immunized with fractional doses of Salmonella enteritidis core and O polysaccharide-flagellin glycoconjugates","volume":"8","author":"Simon","year":"2013","journal-title":"PLoS ONE"},{"issue":"49","key":"10.1016\/j.vaccine.2016.03.072_bib0075","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.1016\/j.vaccine.2013.09.041","article-title":"Safety and tolerability of a live oral Salmonella typhimurium vaccine candidate in SIV-infected nonhuman primates","volume":"31","author":"Ault","year":"2013","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2016.03.072_bib0080","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1128\/IAI.60.11.4679-4686.1992","article-title":"Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine","volume":"60","author":"Watson","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.03.072_bib0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.micpath.2013.05.014","article-title":"Invasive African <i>Salmonella Typhimurium induces bactericidal antibodies against O-antigens","volume":"63","author":"Rondini","year":"2013","journal-title":"Microb Pathog"},{"issue":"8","key":"10.1016\/j.vaccine.2016.03.072_bib0090","doi-asserted-by":"crossref","first-page":"e0134478","DOI":"10.1371\/journal.pone.0134478","article-title":"Production of a Shigella sonnei vaccine based on generalized modules for membrane antigens (GMMA), 1790GAHB","volume":"10","author":"Gerke","year":"2015","journal-title":"PLoS ONE"},{"issue":"24","key":"10.1016\/j.vaccine.2016.03.072_bib0095","doi-asserted-by":"crossref","first-page":"9803","DOI":"10.1073\/pnas.0812431106","article-title":"The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody response","volume":"106","author":"Gil-Cruz","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2016.03.072_bib0100","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1586\/eri.13.27","article-title":"Invasive nontyphoidal Salmonella disease in Africa: current status","volume":"11","author":"MacLennan","year":"2013","journal-title":"Expert Rev Anti Infect Ther"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630069X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630069X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T23:03:25Z","timestamp":1600383805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1630069X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":20,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0264410X1630069X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.072","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nontyphoidal salmonella disease: Current status of vaccine research and development","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 World Health Organization; licensee Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}